We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
IRS Notice 2010-45 was released on May 21, 2010 describing the application procedures for the new $1 billion investment tax credit and cash grants program for certain drug development or other medical advances by taxpayers not employing more than 250 employees
